derinet® Switzerland
Back

Call Warrant with Knock-Out on BioNTech SE

  • Valor 115319985
  • ISIN CH1153199851
  • Symbol OBNBEV
Bid (indicative)
Size
Ask (indicative)
Size
CurrencyCHF
Price on
Sell
Buy
BioNTech SEUSD 
Please note that this is an indication.

Documents

Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.48

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 27.05.2022

Date: 27.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.46

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 26.05.2022

Date: 26.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.45

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 25.05.2022

Date: 25.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.43

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 24.05.2022

Date: 24.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.42

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.79%

Valuation date: 23.05.2022

Date: 23.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.38

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.79%

Valuation date: 20.05.2022

Date: 20.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.36

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.80%

Valuation date: 19.05.2022

Date: 19.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.35

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.80%

Valuation date: 18.05.2022

Date: 18.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.33

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.79%

Valuation date: 17.05.2022

Date: 17.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.32

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.79%

Valuation date: 16.05.2022

Date: 16.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.28

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 13.05.2022

Date: 13.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.28

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 13.05.2022

Date: 13.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.26

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 12.05.2022

Date: 12.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.25

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 11.05.2022

Date: 11.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.23

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.78%

Valuation date: 10.05.2022

Date: 10.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.22

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.79%

Valuation date: 09.05.2022

Date: 09.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.18

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 06.05.2022

Date: 06.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.16

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 05.05.2022

Date: 05.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.15

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 04.05.2022

Date: 04.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.14

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 03.05.2022

Date: 03.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.12

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 02.05.2022

Date: 02.05.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.09

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 29.04.2022

Date: 29.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.07

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 28.04.2022

Date: 28.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.06

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 27.04.2022

Date: 27.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.05

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 26.04.2022

Date: 26.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.04

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.26%

Valuation date: 25.04.2022

Date: 25.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 120.00

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 22.04.2022

Date: 22.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.99

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 21.04.2022

Date: 21.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.97

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 20.04.2022

Date: 20.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.96

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 19.04.2022

Date: 19.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.95

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 18.04.2022

Date: 18.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.91

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 15.04.2022

Date: 15.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.90

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 14.04.2022

Date: 14.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.89

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 13.04.2022

Date: 13.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.87

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 12.04.2022

Date: 12.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.86

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 11.04.2022

Date: 11.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.82

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 08.04.2022

Date: 08.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.81

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 07.04.2022

Date: 07.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.80

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 06.04.2022

Date: 06.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.78

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 05.04.2022

Date: 05.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.77

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 04.04.2022

Date: 04.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.73

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 01.04.2022

Date: 01.04.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.72

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 31.03.2022

Date: 31.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.71

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 30.03.2022

Date: 30.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.70

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 29.03.2022

Date: 29.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.68

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 28.03.2022

Date: 28.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.65

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.27%

Valuation date: 25.03.2022

Date: 25.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.63

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.28%

Valuation date: 24.03.2022

Date: 24.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.62

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.29%

Valuation date: 23.03.2022

Date: 23.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Official Notice

Issuer: Bank Vontobel AG, Zurich
Product: Call Warrant with Knock-Out on BioNTech SE
ISIN: CH1153199851
Valor: 115319985

ADJUSTMENT OF PRODUCT TERMS

The product terms and conditions have been set as follows effective as of the valuation date:

Strike/Knock-out Level: USD 119.61

FURTHER INFORMATION
Name Underlying: BioNTech SE
ISIN Underlying: US09075V1026
Bloomberg Ticker Underlying: BNTX UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 0.00%
Reference interest rate: 0.30%

Valuation date: 22.03.2022

Date: 22.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.60

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.30%

Stichtag: 21.03.2022

Datum: 21.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.56

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 18.03.2022

Datum: 18.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.55

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 17.03.2022

Datum: 17.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.53

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 16.03.2022

Datum: 16.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.52

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 15.03.2022

Datum: 15.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.51

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 14.03.2022

Datum: 14.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.48

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 11.03.2022

Datum: 11.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.46

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 10.03.2022

Datum: 10.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.45

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 09.03.2022

Datum: 09.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.44

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 08.03.2022

Datum: 08.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.43

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 07.03.2022

Datum: 07.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.39

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 04.03.2022

Datum: 04.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.38

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 03.03.2022

Datum: 03.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.37

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 02.03.2022

Datum: 02.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.36

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 01.03.2022

Datum: 01.03.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.35

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 28.02.2022

Datum: 28.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.31

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 25.02.2022

Datum: 25.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.30

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 24.02.2022

Datum: 24.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.29

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 23.02.2022

Datum: 23.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.28

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 22.02.2022

Datum: 22.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.26

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 21.02.2022

Datum: 21.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.23

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 18.02.2022

Datum: 18.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.22

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 17.02.2022

Datum: 17.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.20

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 16.02.2022

Datum: 16.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.19

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 15.02.2022

Datum: 15.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.18

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 14.02.2022

Datum: 14.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.15

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.04%

Stichtag: 11.02.2022

Datum: 11.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.13

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 10.02.2022

Datum: 10.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.12

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 09.02.2022

Datum: 09.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.11

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 08.02.2022

Datum: 08.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.06

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 04.02.2022

Datum: 04.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.05

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 03.02.2022

Datum: 03.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.04

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 02.02.2022

Datum: 02.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.03

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 01.02.2022

Datum: 01.02.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 119.02

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.04%

Stichtag: 31.01.2022

Datum: 31.01.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 118.98

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.04%

Stichtag: 28.01.2022

Datum: 28.01.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 118.97

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 27.01.2022

Datum: 27.01.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 118.96

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.04%

Stichtag: 26.01.2022

Datum: 26.01.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 118.95

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.05%

Stichtag: 25.01.2022

Datum: 25.01.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
Offizielle Mitteilung

Emittentin: Bank Vontobel AG, Zürich
Produkt: Call Warrant mit Knock-Out auf BioNTech SE
Symbol: OBNBEV
CH-Valor: 115319985
ISIN: CH1153199851

ANPASSUNG PRODUKTBEDINGUNGEN

Die Produktbedingungen wurden mit Wirkung zum Stichtag wie folgt festgesetzt:

Strike/Knock-out Level: USD 118.94

WEITERE INFORMATIONEN
Bezeichnung Basiswert: BioNTech SE
ISIN Basiswert: US09075V1026
Bloomberg Ticker Basiswert: BNTX UW Equity
Finanzierungsspread: 3.50%
Stop-Loss Puffer: 0.00%
Referenzzinssatz: 0.04%

Stichtag: 24.01.2022

Datum: 24.01.2022
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Telefon: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
TypeDateTitle
Rule-based Parameter Adjustment27/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment26/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment25/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment24/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment23/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment20/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment19/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment18/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment17/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment16/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment13/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment13/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment12/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment11/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment10/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment09/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment06/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment05/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment04/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment03/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment02/05/2022Adjustment of Product Terms
Rule-based Parameter Adjustment29/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment28/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment27/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment26/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment25/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment22/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment21/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment20/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment19/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment18/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment15/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment14/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment13/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment12/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment11/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment08/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment07/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment06/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment05/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment04/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment01/04/2022Adjustment of Product Terms
Rule-based Parameter Adjustment31/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment30/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment29/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment28/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment25/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment24/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment23/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment22/03/2022Adjustment of Product Terms
Rule-based Parameter Adjustment21/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment18/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment17/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment16/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment15/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment14/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment11/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment10/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment09/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment08/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment07/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment04/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment03/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment02/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment01/03/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment28/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment25/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment24/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment23/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment22/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment21/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment18/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment17/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment16/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment15/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment14/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment11/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment10/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment09/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment08/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment04/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment03/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment02/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment01/02/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment31/01/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment28/01/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment27/01/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment26/01/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment25/01/2022Anpassung Produktbedingungen
Rule-based Parameter Adjustment24/01/2022Anpassung Produktbedingungen